Clinical Trials Browser

Phase NA × NIH × Flow Cytometry × Clear all

NCT00436709 2014-01-06

Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer

Phase NA Unknown

Breast Neoplasms, Breast Neoplasms, Male

NCT00689975 2013-08-26

Diet and Exercise or Normal Care in Overweight or Obese Women Who Have Undergone Treatment for Stage I, Stage II, or Stage III Breast Cancer

Phase NA Completed

Breast Neoplasms